Journal of Cytology
Home About us Ahead of print Instructions Submission Subscribe Advertise Contact e-Alerts Login 
Users Online:486
  Print this page  Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others

ORIGINAL ARTICLE

Use of panel of markers in serous effusion to distinguish reactive mesothelial cells from adenocarcinoma

Subbarayan Devi, Bhattacharya Jenna, Rani Poonam, Khuraijam Bembem, Jain Shyama

Year : 2019| Volume: 36| Issue : 1 | Page no: 28-31

   This article has been cited by
 
1 Prognostic Significance of Intraoperative Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma: A Single-Center Experience and Systematic Review of the Literature
Shoji Kawakatsu, Yasuhiro Shimizu, Seiji Natsume, Masataka Okuno, Seiji Ito, Koji Komori, Tetsuya Abe, Kazunari Misawa, Yuichi Ito, Takashi Kinoshita, Eiji Higaki, Hironori Fujieda, Yusuke Sato, Akira Ouchi, Masato Nagino, Kazuo Hara, Keitaro Matsuo, Waki Hosoda
Annals of Surgical Oncology. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Epithelial Membrane Antigen, Vimentin, Desmin, Calretinin, E-Cadherin on Cell Block Preparations to Distinguish Well Differentiated Adenocarcinoma from Benign, Reactive, Atypical Mesothelial Cells
Neha Jaiswal, Jayant Makrande, Sunita Vagha
Journal of Evolution of Medical and Dental Sciences. 2021; 10(18): 1302
[Pubmed]  [Google Scholar] [DOI]
3 Role of CD68 immunohistochemistry in categorizing benign nonmesothelial cell population and refining “atypical” category in serous fluid cytology
Omid Savari, Sarmad Jassim, Hector Ferrer, Stephen J. Ganocy, Santhi Ganesan
Diagnostic Cytopathology. 2020; 48(12): 1199
[Pubmed]  [Google Scholar] [DOI]

 

Read this article